Bacterial translocation in HIV-infected patients with HCV cirrhosis: Implication in hemodynamic alterations and mortality

Journal of Acquired Immune Deficiency Syndromes

Volumn 56, Issue 5, 2011, Pages 420-427

  De Oca Arjona, Montserrat Montes ^a   Marquez, Mercedes ^a   Soto, Maria Jose ^a   Rodriguez Ramos, Claudio ^a   Terron, Alberto ^b   Vergara, Antonio ^c   Arizcorreta, Ana ^a   Fernandez Gutierrez, Clotilde ^a   Giron González, Jose Antonio ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^b HOSPITAL DE JEREZ   (Spain)

^c HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

Author keywords

Hepatitis C Virus; Human Immunode ficiency virus; interleukin 6; intestinal permeability; liver cirrhosis

Indexed keywords

ALDOSTERONE; CD14 ANTIGEN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE BINDING PROTEIN; SOLUBLE CD4 ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; BACTERIAL TRANSLOCATION; CD4+ T LYMPHOCYTE; COMORBIDITY; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; FEMALE; FOLLOW UP; HEMODYNAMICS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTESTINE MUCOSA PERMEABILITY; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PORTAL HYPERTENSION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SURVIVAL;

ACUTE-PHASE PROTEINS; ADULT; BACTERIAL TRANSLOCATION; CARRIER PROTEINS; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; HYPERTENSION, PORTAL; INTERLEUKIN-6; INTESTINES; LIVER CIRRHOSIS; MACROPHAGE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PERMEABILITY; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 79953041117     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31820ef408     Document Type: Article

References (36)

1. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus co-infected patients. Hepatology. 1999;30:1054-1058. (Pubitemid 29458296)
2. Martinez-Sierra C, Arizcorreta A, D́az F, et al. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients co-infected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis. 2003;36:491-498. (Pubitemid 36241318)
3. Girón-González JA, Brun F, Terrón A, et al. Natural history of compensated and decompensated HCV-related cirrhosis in HIV-infected patients: a prospective multicentre study. Antivir Ther. 2007;12:899-907. (Pubitemid 47492559)
4. Pineda JA, Romero-Gómez M, Diaz-Garća F, et al. HIV co-infection shortens the survival of patients with hepatitis C virus-related decom-pensated cirrhosis. Hepatology. 2005;41:779-789. (Pubitemid 40462940)
5. Bonacini M, Louie S, Bzowej N, et al. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS. 2004;18: 2039-2045. (Pubitemid 39463357)
6. Merchante N, Girón-González JA, González-Serrano M, et al. Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS. 2006;20:49-57. (Pubitemid 41818114)
7. Guadalupe M, Reay E, Sankaran S, et al. Severe CD4+ T cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol. 2003;77:11708-11717. (Pubitemid 37271669)
8. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365-1371. (Pubitemid 44924494)
9. Bruno R, Sachi P, Puoti M, et al. Pathogenesis of liver damage in HCV-HIV patients. AIDS Rev. 2008;10:15-24. (Pubitemid 351524048)
10. Schumann RR, Latz E. Lipopolysaccharide binding protein. Chem Immunol. 2000;74:42-60.
11. Navasa M, Follo A, Filella X, et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology. 1998;27: 1227-1232. (Pubitemid 28227848)
12. Limuro Y, Galuuci RM, Luster MI, et al. Antibodies to tumor necrosis factor alpha attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology. 1997;26:1530-1537.
13. Genesca J, Gonzalez A, Segura R, et al. Interlueukin-6, nitric oxide and the clinical and hemodynamic alterations of patients with liver cirrhosis. Am J Gastroenterol. 1999;94:169-177. (Pubitemid 29063463)
14. Cirera I, Bauer TM, Navasa M, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol. 2001;34:32-37.
15. Albillos A, de la Hera A, Gonzalez M, et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology. 2003;37:208-217. (Pubitemid 36042162)
16. Albillos A, de la Hera A, Alverez-Mon M. Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites. Lancet. 2004;363:1608-1610. (Pubitemid 38625665)
17. Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis. Clin Infect Dis. 2001;33:562-569. (Pubitemid 32709592)
18. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994;19:1513-1520. (Pubitemid 24166476)
19. Tchelepi H, Ralls PW, Radin R, et al. Sonography of diffuse liver disease. J Ultrasound Med. 2002;21:1023-1032. (Pubitemid 34988610)
20. Pugh RNH, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60: 646-649.
21. Ragni MV, Belle SH, Im K, et al. Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis. 2003;188: 1412-1420. (Pubitemid 37523925)
22. Porteu F, Nathan C. Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med. 1990;172:599-607. (Pubitemid 20248401)
23. Porcel A, D́az F, Rendón P, et al. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med. 2002;162:323-328. (Pubitemid 34127410)
24. Nowroozalizadeh S, Mansson F, Da Silve, et al. Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections. J Infect Dis. 2010;201:1150-1154.
25. Paiardini M, Frank I, Pandrea I, et al. Mucosal immune dysfunction in AIDS pathogenesis. AIDS Rev. 2008;10:36-46. (Pubitemid 351524050)
26. Tinoco I, Girón-González JA, González- González MT, et al. Efficacy of directly observed treatment of HIV infection: experience in AIDS welfare homes. Eur J Clin Microbiol Infect Dis. 2004;23:331-335. (Pubitemid 38678640)
27. Maćas J, Mira JA, López-Cortés L, et al. Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C. Antivir Ther. 2006;11:839-846. (Pubitemid 44736175)
28. Garcia-Tsao G, Friedman S, Iredale J, et al. Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology. 2010;51:1445-1449.
29. Schrier RW, Arroyo V, Bernardi M, et al. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988;8:1151-1157.
30. Huo TI, Lin HC, Huo SC, et al. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis. Liver Transpl. 2008; 14:837-844. (Pubitemid 351895513)
31. Llach J, Gines P, Arroyo V, et al. Prognostic value of arterial pressure, endogenous vasoactive systems and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology. 1988;94:482-487. (Pubitemid 18054789)
32. Wang JJ, Gao GW, Gao RZ, et al. Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension. World J Gastroenterol. 2004;10:689-693.
33. Girón-González JA, Mart́nez-Sierra C, Rodriguez-Ramos C, et al. Implication of inflammation-related cytokines in the natural history of liver cirrhosis. Liver Int. 2004;24:437-445. (Pubitemid 40484557)
34. Rodriguez-Ramos C, Galan F, Diaz F, et al. Expression of pro-inflammatory cytokines and their inhibitors during the course of spontaneous bacterial peritonitis. Dig Dis Sci. 2001;46:1668-1676. (Pubitemid 32727097)
35. Romero-Gómez M, Jover M, Galán JJ, et al. Gut ammonia production and its modulation. Metab Brain Dis. 2009;24:147-157.
36. Shawcross DL, Davies NA, Williams R, et al. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyper-ammonemia in cirrhosis. J Hepatol. 2004;40:247-254. (Pubitemid 38115829)